Regulation of PTP1B activation through disruption of redox-complex formation

Avinash D Londhe1, Alexandre Bergeron2,3, Stephanie M Curley1

  • 1Department of Nanobioscience, College of Nanoscale Science and Engineering, SUNY Polytechnic Institute, Albany, NY, USA.

Nature Chemical Biology
|December 25, 2019
PubMed

Insights

Researchers found that blocking the interaction between protein tyrosine phosphatase 1B (PTP1B) and 14-3-3ζ prevents PTP1B inactivation and may offer a way to activate PTP1B in cells.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Enzymology

Background:

  • Protein tyrosine phosphatase 1B (PTP1B) is a key regulator of cellular signaling pathways.
  • PTP1B activity is modulated by post-translational modifications, including reversible oxidation.
  • 14-3-3 proteins are known to interact with and regulate various signaling molecules.

Purpose of the Study:

  • To investigate the molecular interaction between PTP1B and 14-3-3ζ.
  • To determine the role of this interaction in regulating PTP1B activity.
  • To explore the potential of modulating this interaction for therapeutic purposes.

Main Methods:

  • Biochemical assays to detect and characterize the PTP1B-14-3-3ζ interaction.
  • Cell-based experiments to assess the impact of disrupting the interaction on PTP1B activity and downstream signaling.
  • Measurement of epidermal growth factor receptor (EGFR) phosphorylation levels.

Main Results:

  • A novel molecular interaction was identified between the reversibly oxidized form of PTP1B and 14-3-3ζ.
  • Destabilizing this transient interaction prevented PTP1B inactivation by reactive oxygen species.
  • Disruption of the interaction led to decreased epidermal growth factor receptor phosphorylation.

Conclusions:

  • The interaction between 14-3-3ζ and oxidized PTP1B is crucial for PTP1B inactivation.
  • Modulating this interaction offers a potential strategy for controlling PTP1B activity.
  • Targeting the PTP1B-14-3-3ζ interaction may provide a novel therapeutic approach for diseases involving PTP1B dysregulation.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
19.4K
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
8.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K